RedHill Biopharma Ltd. (RDHL) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 |
|---|
| Sales/Revenue | 2.04M | 2.04M | 2.74M | 2.74M | 1.29M | 1.29M | 567.5K | 567.5K | 1.8M | 3.6M | 12.8M | 17.55M | 18.35M | 13.1M | 22.07M | 21.61M | 21.5M | 20.57M | 21.46M | 20.94M |
| Revenue Growth % | 58.59% | 58.59% | 382.03% | 382.03% | -28.4% | -64.27% | -95.57% | -96.77% | -90.21% | -72.54% | -42.01% | -18.77% | -14.68% | -36.31% | 2.84% | 3.18% | 2.89% | 1848.39% | 1249.75% | 1394.86% |
| Cost of Goods Sold | 803.5K | 803.5K | 894K | 894K | 702K | 702K | 520.5K | 520.5K | 806K | 1.61M | 8.6M | 9.45M | 8.99M | 6.29M | 19.33M | 9.23M | 10.59M | 10.25M | 10.65M | 10.34M |
| COGS % of Revenue | 39.4% | 39.4% | 32.68% | 32.68% | 54.59% | 54.59% | 91.72% | 91.72% | 44.88% | 44.79% | 67.18% | 53.85% | 49.03% | 48.02% | 87.6% | 42.71% | 49.25% | 49.83% | 49.63% | 49.36% |
| Gross Profit | 1.24M | 1.24M | 1.84M | 1.84M | 584K | 584K | 47K | 47K | 990K | 1.99M | 4.2M | 8.1M | 9.35M | 6.81M | 2.74M | 12.38M | 10.91M | 10.32M | 10.81M | 10.61M |
| Gross Margin % | 60.6% | 60.6% | 67.32% | 67.32% | 45.41% | 45.41% | 8.28% | 8.28% | 55.12% | 55.21% | 32.82% | 46.15% | 50.97% | 51.98% | 12.4% | 57.29% | 50.75% | 50.17% | 50.37% | 50.64% |
| Gross Profit Growth % | 111.64% | 111.64% | 3818.09% | 3818.09% | -41.01% | -70.61% | -98.88% | -99.42% | -89.41% | -70.83% | 53.45% | -34.56% | -14.31% | -34.01% | -74.68% | 16.73% | 62.6% | 1666.31% | 1247.76% | 1273.83% |
| Operating Expenses | 3.42M | 3.42M | 4.92M | 4.92M | 4.81M | 4.81M | 6.07M | 6.07M | 5.4M | -27.09M | 14.15M | 15.21M | 18.51M | 23.44M | 23.44M | 29.78M | 35.8M | 28.47M | 30.52M | 25.07M |
| OpEx % of Revenue | 167.93% | 167.93% | 180% | 180% | 373.87% | 373.87% | 1069.07% | 1069.07% | 300.56% | -752.79% | 110.55% | 86.65% | 100.89% | 178.88% | 106.18% | 137.8% | 166.49% | 138.39% | 142.2% | 119.69% |
| Selling, General & Admin | 2.94M | 2.94M | 3.28M | 3.28M | 4.48M | 4.48M | 6M | 6M | 8.06M | 10.91M | 13.02M | 13.6M | 17.04M | 20.38M | 17.57M | 23.96M | 25.47M | 20.99M | 24.33M | 20.74M |
| SG&A % of Revenue | 144.3% | 144.3% | 119.91% | 119.91% | 348.25% | 348.25% | 1057.97% | 1057.97% | 448.78% | 303.06% | 101.7% | 77.47% | 92.87% | 155.51% | 79.6% | 110.88% | 118.45% | 102.02% | 113.36% | 99.05% |
| Research & Development | 482K | 482K | 464.5K | 464.5K | 329.5K | 329.5K | 598.5K | 598.5K | 1.25M | 1.08M | 1.13M | 1.61M | 1.47M | 3.06M | 5.87M | 5.82M | 10.33M | 7.48M | 6.19M | 4.32M |
| R&D % of Revenue | 23.63% | 23.63% | 16.98% | 16.98% | 25.62% | 25.62% | 105.46% | 105.46% | 69.43% | 30.12% | 8.85% | 9.18% | 8.02% | 23.37% | 26.59% | 26.92% | 48.03% | 36.37% | 28.84% | 20.64% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 0 | 0 | -535.5K | -535.5K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.19M | -2.19M | -3.08M | -3.08M | -4.22M | -4.22M | -6.02M | -6.02M | -4.41M | 29.08M | -9.95M | -7.11M | -9.16M | -16.63M | -20.7M | -17.4M | -24.89M | -18.15M | -19.71M | -14.46M |
| Operating Margin % | -107.33% | -107.33% | -112.69% | -112.69% | -328.46% | -328.46% | -1060.79% | -1060.79% | -245.43% | 808% | -77.73% | -40.5% | -49.92% | -126.9% | -93.78% | -80.51% | -115.74% | -88.22% | -91.83% | -69.04% |
| Operating Income Growth % | 48.18% | 48.18% | 48.8% | 48.8% | 4.17% | -114.53% | 39.49% | 15.31% | 51.87% | 274.88% | 51.94% | 59.14% | 63.2% | 8.39% | -5.03% | -20.32% | -99.09% | -6.68% | -67.53% | -46.89% |
| EBITDA | -2.1M | -2.1M | -3.06M | -3M | -4.01M | -4.01M | -5.84M | -5.64M | -63.31M | 89.56M | -7.94M | -5.02M | -7.24M | -14.49M | -9.51M | -15.06M | -22.59M | -15.83M | -17.16M | -11.88M |
| EBITDA Margin % | -103.21% | -103.21% | -111.79% | -109.54% | -312.21% | -312.21% | -1029.34% | -993.27% | -3524.94% | 2488.61% | -62.04% | -28.58% | -39.48% | -110.58% | -43.07% | -69.68% | -105.06% | -76.95% | -79.95% | -56.73% |
| EBITDA Growth % | 47.57% | 47.57% | 47.65% | 46.84% | 93.66% | -104.48% | 26.43% | -12.38% | -774.06% | 718.07% | 16.47% | 66.69% | 67.94% | 8.48% | 44.6% | -26.73% | -119.12% | -1.56% | -51.91% | -24.33% |
| D&A (Non-Cash Add-back) | 84K | 84K | 24.5K | 86K | 209K | 209K | 178.5K | 383.17K | -58.9M | 60.48M | 2.01M | 2.09M | 1.92M | 2.14M | 11.19M | 2.34M | 2.29M | 2.32M | 2.55M | 2.58M |
| EBIT | -2.19M | -2.19M | -1.9M | -1.9M | -4.22M | -4.22M | -6.02M | -6.02M | 2.69M | 50.66M | -2.3M | -3.92M | -7.5M | -16.62M | -20.78M | -17.38M | -24.87M | -18.11M | -20.09M | -14.42M |
| Net Interest Income | -512K | -512K | 913K | 913K | -874K | -874K | 1.04M | 1.04M | 5.17M | 21.16M | -6.21M | -28.59M | -2.55M | -3.9M | -3.69M | -3.99M | -4.24M | -4.71M | 4.41M | -4.18M |
| Interest Income | 0 | 0 | 913K | 913K | 0 | 0 | 1.04M | 1.04M | 7.09M | 21.58M | 0 | 3.19M | 1.66M | 10K | 12.05K | 17K | 15K | 42K | 4.41M | 42K |
| Interest Expense | 512K | 512K | 0 | 0 | 874K | 874K | 0 | 0 | 1.93M | 421K | 1.43M | 31.78M | 4.21M | 3.91M | 3.7M | 4.01M | 4.25M | 4.75M | 0 | 4.22M |
| Other Income/Expense | 122.5K | 122.5K | 492.5K | 492.5K | 2.68M | 2.68M | -7.52M | -7.52M | 5.17M | 21.16M | 6.22M | -28.59M | -2.55M | -3.9M | -3.67M | -3.99M | -4.24M | -4.71M | -4.62M | -4.18M |
| Pretax Income | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -20.53M | -24.37M | -21.39M | -29.12M | -22.86M | -24.33M | -18.64M |
| Pretax Margin % | -101.32% | -101.32% | -94.68% | -94.68% | -120.06% | -120.06% | -2386.43% | -2386.43% | 42.37% | 1395.97% | -29.14% | -203.4% | -63.83% | -156.65% | -110.43% | -98.97% | -135.43% | -111.12% | -113.37% | -88.99% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -20.53M | -24.37M | -21.39M | -29.12M | -22.86M | -24.33M | -18.64M |
| Net Margin % | -101.32% | -101.32% | -94.68% | -94.68% | -120.06% | -120.06% | -2386.43% | -2386.43% | 42.37% | 1395.97% | -29.14% | -203.4% | -63.83% | -156.65% | -110.43% | -98.97% | -135.43% | -111.12% | -113.37% | -88.99% |
| Net Income Growth % | -33.84% | -33.84% | 80.88% | 80.88% | -302.89% | -103.07% | -263.18% | 62.07% | 106.5% | 344.74% | 84.7% | -66.93% | 59.78% | 10.21% | -0.17% | -14.75% | -81.47% | -33.26% | -108.12% | -89.51% |
| Net Income (Continuing) | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -20.53M | -24.37M | -21.39M | -29.12M | -22.86M | -24.33M | -18.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -17.00 | -24.00 | 3.00 | 256.00 | -20.00 | -282.00 | -103.00 | -195.00 | -244.00 | -228.00 | -312.00 | -266.00 | -317.00 | -250.00 |
| EPS Growth % | 0% | 0% | 94.12% | 95.83% | -133.33% | -100.39% | 15% | 91.49% | 102.91% | 231.28% | 91.8% | -23.68% | 66.99% | 26.69% | 23.03% | 8.8% | -39.29% | -9.46% | -92.12% | -44.51% |
| EPS (Basic) | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -17.00 | -24.00 | 3.00 | 256.00 | -20.00 | -282.00 | -103.00 | -195.00 | -244.00 | -228.00 | -312.00 | -266.00 | -317.00 | -250.00 |
| Diluted Shares Outstanding | 1.8M | 1.8M | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K | 76.8K | 74.58K |
| Basic Shares Outstanding | 1.8M | 1.8M | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K | 76.8K | 74.58K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |